Diversified Consumer Services
Company Overview of University of Alabama at Birmingham
University of Alabama at Birmingham (UAB) is an educational institution that offers undergraduate and graduate programs in arts, biochemistry, chemistry, engineering, environment, and nursing. The schools of the university include School of Arts & Humanities, School of Business, School of Engineering School of Medicine School of Nursing, and School of Public Health. UAB was founded in 1969 and is based in Birmingham, Alabama. It has endowment assets worth $247.6 millions.
701 20th St S Ab1070
Birmingham, AL 35233-2031
Founded in 1936
Key Executives for University of Alabama at Birmingham
Chief Executive Officer of The University of Alabama-Birmingham Research Foundation
Chief Executive Officer of Health System
Associate Provost for Administration and Finance
Dean of School of Business
Compensation as of Fiscal Year 2016.
University of Alabama at Birmingham Key Developments
Proton International and the University of Alabama At Birmingham to Develop State’s First Proton Treatment Center
Jun 27 16
Proton International has signed a Memorandum of Understanding with the University of Alabama at Birmingham to develop a proton treatment center. The University of Alabama at Birmingham Health System (UAB Medicine) is the fourth organization to sign an agreement to work with Proton International (PI) to build a center providing proton therapy, a highly effective and precise alternative to traditional radiation therapy for treating cancer and some non-cancerous tumors but without many of the side effects that often accompany treatment. UAB Medicine will be among a select group of hospitals in the country to offer advanced proton therapy technology using a fully featured compact system with dynamic peak pencil beam scanning, developed by Varian Medical Systems.
Spotlight Innovation Inc. Enters into Research Agreement with University of Alabama At Birmingham
Mar 16 16
Spotlight Innovation Inc. entered into a Research Agreement with the University of Alabama at Birmingham to conduct studies to validate the efficacy of Spotlight Innovation's Immunoplex immunotherapy platform technology for metastatic breast cancer in mouse models. These pre-clinical studies are anticipated to take approximately six months and are intended to validate significant and highly favorable prior test data. The data will be submitted as part of an Investigational New Drug filing with the U.S. Food and Drug Administration. Lyse A. Norian, PhD, is the Principal Investigator. Dr. Norian conducted the original studies during her tenure at the University of Iowa. The study protocol includes the examination of primary tumor growth in mice, the examination of metastatic tumor growth in mice with resected primary tumors, and analyses of tumor-infiltrating and systemic leukocytes in tumor-bearing mice.
The University of Alabama At Birmingham Wins $24.89 Million Federal Contract
Jul 11 15
The University of Alabama at Birmingham, Alabama, won a $24,888,105 federal contract from NASA's Johnson Space Center, Houston, for powered space refrigerator and freezer support services.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries